Back to Search
Start Over
US FDA accepts Allergan's sNDA filing for Avycaz
- Source :
- PharmaBiz. October 4, 2017
- Publication Year :
- 2017
-
Abstract
- Allergan plc, a leading global pharmaceutical company, announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Avycaz (ceftazidime and avibactam) for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.507968448